The disclosure provides compounds and methods of using Apogossypolone derivatives for treating diseases and disorders. In particular, the disclosure provides compounds of Formula (I): or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and provides methods for the preparation of compounds of Formula (I)； and methods for treating cancer, autoimmune diseases, and inflammation by administering a compound of Formula (I).
